MedPath
HSA Approval

APO-DIMENHYDRINATE TABLET 50 mg

SIN02519P

APO-DIMENHYDRINATE TABLET 50 mg

APO-DIMENHYDRINATE TABLET 50 mg

April 17, 1989

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A04AD

其它镇吐药

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

DIMENHYDRINATE BP

50 mg

Dimenhydrinate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-DIMENHYDRINATE TABLET 50 mg - HSA Approval | MedPath